Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Perspectives on the safety of a JAK inhibitor in RA, PsA, and AS – Featuring Drs Wickersham, Winthrop, and Ritchlin Sponsored by AbbVie Medical Affairs

    Perspectives on the safety of a JAK inhibitor in RA, PsA, and AS – Featuring Drs Wickersham, Winthrop, and Ritchlin Sponsored by AbbVie Medical Affair…

    FromRheumnow Podcast

    Start listeningView podcast show

    Perspectives on the safety of a JAK inhibitor in RA, PsA, and AS – Featuring Drs Wickersham, Winthrop, and Ritchlin Sponsored by AbbVie Medical Affair…

    FromRheumnow Podcast

    ratings:
    Length:
    24 minutes
    Released:
    Sep 30, 2022
    Format:
    Podcast episode

    Description

    Drs. Pendleton Wickersham (Arthritis Associates PA, San Antonio, TX), Kevin Winthrop (OHSU, Portland, OR), and Christopher Ritchlin (URMC, Rochester, NY) come together to share their experiences discussing with patients the benefit-risk of a JAK inhibitor.
    Released:
    Sep 30, 2022
    Format:
    Podcast episode

    Titles in the series (100)

    Dr Jack Cush reviews the news, journal reports and FDA approvals